News & Events
- News
- Webinars
- Events
Resource Library
Careers
Training

Top Bar

MENUMENU

About UsAbout Us
Our Services
- Discovery / Non-clinical
  - - - Go to Discovery / Non-clinical section >>
  - - - Strategy and Consulting
        Development Strategy and Gap Analysis
        Integrated Product Development
        Market Access Strategy
        Non-clinical Development Concept
        and Study Design
        Scientific Advice
        Scientific Due Diligence
        Statistical Services
        Toxicology Services
- Clinical Development
  - - - Go to Clinical Development section >>
  - - - Strategy and Consulting
        Clinical Program Development
        Orphan Drug Designation
        Pediatric Investigation Plan (PIP)
        Scientific Advice
        Statistical Services
      - Regulatory Affairs
        Clinical Trial Applications (CTA)
        Global Procedure Management
        Health Authority / Agency Interaction
        Regulatory Operations
    - - Pharmacovigilance
        Clinical Trial Safety Support
        Pharmacovigilance Consulting
      - Quality
        GxP Services
        IMP Management
        Interim / Contract QA
        Quality Systems
        Tech Transfer / Scale-up
        Vendor Management and Oversight
- Authorization / Approval
  - - - Go to Authorization / Approval section >>
  - - - Strategy and Consulting
        Market Access
      - Regulatory Affairs
        CMC Services
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Regulatory Operations
        Scientific, Regulatory and Technical Writing
        Statistical Services
    - - Pharmacovigilance
        EU QPPV / National QPPV
        Pharmacovigilance Consulting
      - Quality
        Commercialization Readiness
        Commissioning, Qualification, and Validation (CQV)
        GxP Services
        Interim / Contract QA
        PAI Readiness
- Post-approval / Maintenance
  - - - Go to Post-approval / Maintenance section >>
  - - - Strategy and Consulting
        Environmental Risk Assessment
        Market Access
      - Regulatory Affairs
        CMC Services
        Global End-to-End Outsourcing
        Global Procedure Management
        Health Authority / Agency Interaction
        Marketing and Labeling Activities
        Mergers and Acquisitions (M&A) Transfers
        Regulatory Operations
        Toxicology Services
      - Pharmacovigilance
        Audit and CAPA Management
        EU QPPV / National QPPV
        ICSR Management
        Literature Screening
        Pharmacovigilance Systems
        Safety Writing (PSUR, RMP)
        Signal Management
    - - Quality
        Commissioning, Qualification, and Validation (CQV)
        Good Distribution Practice (GDP) Compliance
        GxP Services
        Interim / Contract QA
        Quality Systems
        Vendor Audit
        Vendor Management and Oversight
      - Medical Affairs
        Healthcare Compliance and Medical Approval
        Medical Information
- Program Management
  - - - Go to Program Management section >>
      - Program Management
        Global End-to-End Outsourcing
        Global Procedure Management
        Integrated Product Development
        Mergers and Acquisitions (M&A) Transfers
- Featured Expertise
  - - - Industry Expertise
        Biopharmaceuticals
        Consulting
        Consumer Healthcare
        Generics
        Herbal Medicines
        Medicinal Products
        MedTech Services
        Pharmaceutical
        Veterinary Drugs
    - - Service Expertise
        ATMP / Cell and Gene Therapy
        Brexit
        COVID-19 Support
        Drug Re-purposing / Value-added Medicines
        GxP Services
        Market Access
        Pharmacovigilance Consulting
        Statistical Services
      - SMARTPHLEX - technology-enabled services
Global ReachGlobal Reach
Contact usContact us
News & Events
Resource Library
Careers
Training

Home > News & Events > News > Page 8

News

CMDh releases public consultation on allergan products

18th July 2019

The importance of GxP Compliance for Global Cannabis Production

25th June 2019

Good Distribution Practices of Medicinal Products

12th June 2019

Pharmaceutical Facility Design

29th May 2019

QRM requirements from Draft Annex 1

22nd May 2019

FDA Inspection Readiness – is your company ready?

13th May 2019

Brexit: Guidance on Batch Testing

9th May 2019

Quality Considerations for Manufacturing in Pharma

30th April 2019

2 3 4 5

…6 7 8 9 10 …

11 12 13 14 15 16 17 18 19 20

prev next

Upcoming Webinars

January 26th, 2021

Unlocking BLA, NDA, IND Submissions

5 PM CET

February 2nd, 2021

Central American Regulation for Drug Products (LATAM)

3 PM CET

February 25th, 2021

What you need to know to submit Study Data to FDA

5PM CET

Archive

USEFUL LINKS

Home
Contact us
Imprint
Data Protection
Terms and Conditions

RECENT TWEETS

Tweets by @PharmaLexGLOBAL

COVID-19 NEWSLETTER SIGN UP

WHAT OUR CLIENTS SAY

Pharmalex provided the resources we needed to compile Investigational Medicinal Product Dossiers for our biological products. The dossiers were delivered on time with the trusted quality we expected

Small US Biopharmaceutical Company
Sr Director Regulatory Affairs CMC

ISO9001:2015 Logo

#AskTheExpert #TogetherBEYONDCOVID19

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
You can unsubscribe at any time at data.protection@pharmalex.com

Please leave this field empty.

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

#TogetherBEYONDCOVID19

We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

Please DO NOT send us event/conference information.
We will not respond and these will be deleted immediately.

Select your state:

Please tick this box to agree to our Privacy Policy

Please tick this box if you agree to periodic updates from PharmaLex.
You can unsubscribe at any time at data.protection@pharmalex.com

Please leave this field empty.

If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

This can be specific information about signing up to the newsletter.

Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.

Strategy and Consulting

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Strategy and Consulting

Regulatory Affairs

Pharmacovigilance

Quality

Medical Affairs

Program Management

Industry Expertise

Service Expertise

CMDh releases public consultation on allergan products

Quality Operations Efficiency

The importance of GxP Compliance for Global Cannabis Production

Good Distribution Practices of Medicinal Products

Pharmaceutical Facility Design

TOPRA Annual Meeting 2019

CPhI Worldwide 2019

QRM requirements from Draft Annex 1

FDA Inspection Readiness – is your company ready?

Brexit: Guidance on Batch Testing

Quality Considerations for Manufacturing in Pharma